Dr Chen's research is focused on biomaterials, biomedical engineering, and the application of nanomaterials in biology and medicine. In these areas, he has been working on physical (microneedle & nanoneedle arrays) and chemical (nanomaterials) for drug delivery and sensing.
He has published over 100 papers in peer-reviewed journals including Nature Communications, Advanced Materials, Angewandte Chemie International Edition, Advanced Functional Materials, Small, Advanced Healthcare Materials, Journal of the American Chemical Society, Nano Letters, ACS Nano, Biomaterials, Journal of Controlled Release, Advanced Drug Delivery Reviews, and Chemical Society Reviews. These publications generated an h-index of 45 and > 5500 citations. Additionally, he has 2 book chapters and 12 granted patents & 15 patent applications in drug delivery technologies in major countries and regions, mosted in the USA.
MSc in Chemistry, National University of Singapore
Professional Qualifications and Memberships:
Fellow of the Higher Education Academy (HEA), United Kingdom
Member of the Royal Society of Chemistry (RSC), United Kingdom
Committee member of the Biotechnology Group of the Royal Society of Chemistry, United Kingdom
Process Plant Engineering CHEE08016
Nanomaterials in Chemical & Biomedical Engineering CHEE11026 (With Dr Norbert Radacsi)
Broadly, our research areas of interest include advanced drug delivery systems, biomaterials, biomedical engineering, materials chemistry, and nanomaterials & nanotechnology. We carry out research spanning from materials design, synthesis, and characterisation to preclinical in vitro and in vivo test as well as understanding the underlying biological mechanisms.
Specifically, our current research includes:
Nanomedicines for breast and prostate cancers and their metastases;
Imaging probes for magnetic resonance imaging and fluorescence microscopy;
Nanoneedle arrays for high-throughput intracellular delivery and biosensing;
Wearable and flexible healthcare devices;
Nanomaterials for antibacterial applications.
We welcome outstanding PhD applicants to join our group. The University of Edinburgh and the School of Engineering provide PhD scholarships for exceptional applicants. We also welcome the applicants who have alternative funding support.
Selected publications (*Corresponding authors; vast majority papers appearing in field's top 10% journals)
US patent 10022322, US patent 9220678, Canadian patent 2745339, European patent 2379160, US patent 8734697, US patent 9526884, US patent 9394547, US patent 9469808, US patent 9603795, Australian patent 2008341030, PRC patent CN103816611, PRC patent CN104178414
Advanced drug delivery systems
Cancer therapy and diagnosis
Nanomaterials and nanotechnology
We welcome outstanding PhD applicants to join our group to perform research in bioengineering, biomaterials, and the application of nanomaterials in biology, medicine, and healthcare. Except the research group funding, the following scholarships can be applied to support your study. These are just a few examples, rather than the full list. The School of Engineering also provides PhD scholarships for exceptional applicants.
Currently, we have an EPSRC/MRC CDT scholarship for urgent application (Project 2: Imaging tumour macrophage polarisation for non-invasive evaluation of anticancer therapy). The applicants must be UK citizens or EU citizens who have been living in the UK for a minimum of 3 years. The deadline is 26/07/2018.
Postdoctoral researchers are welcome to join the group to perform research in bioengineering, biomaterials, and the application of nanomaterials in biology, medicine, environment and energy. Outstanding applicants can consider the following fellowship (just a few examples).